ARIAANS; Gerardus Joseph Andreas

Patent Applications and Registrations

Patent applications and USPTO patent grants for ARIAANS; Gerardus Joseph Andreas.The latest application filed is for "site-specific conjugation of linker drugs to antibodies and resulting adcs".

Company Profile

5.6.10

ARIAANS; Gerardus Joseph Andreas - Nijmegen NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Site-specific Conjugation Of Linker Drugs To Antibodies And Resulting Adcs App 20210388115 - ARIAANS; Gerardus Joseph Andreas ; et al.	2021-12-16
Anti-5t4 Antibodies And Antibody-drug Conjugates App 20210317231 - VAN DER LEE; Miranda Maria Cornelia ; et al.	2021-10-14
Site-specific conjugation of linker drugs to antibodies and resulting ADCS Grant 11,136,633 - Ariaans , et al. October 5, 2	2021-10-05
Site-specific conjugation of linker drugs to antibodies and resulting ADCS Grant 11,104,968 - Ariaans , et al. August 31, 2	2021-08-31
Anti-5T4 antibodies and antibody-drug conjugates Grant 11,008,400 - Van der Lee , et al. May 18, 2	2021-05-18
Site-specific Conjugation Of Linker Drugs To Antibodies And Resulting Adcs App 20190367999 - ARIAANS; Gerardus Joseph Andreas ; et al.	2019-12-05
Site-specific Conjugation Of Linker Drugs To Antibodies And Resulting Adcs App 20190368000 - ARIAANS; Gerardus Joseph Andreas ; et al.	2019-12-05
Site-specific conjugation of linker drugs to antibodies and resulting ADCs Grant 10,407,743 - Ariaans , et al. Sept	2019-09-10
Anti-5t4 Antibodies And Antibody-drug Conjugates App 20190194346 - VAN DER LEE; Miranda Maria Cornelia ; et al.	2019-06-27
Site-specific Conjugation Of Linker Drugs To Antibodies And Resulting Adcs App 20170080103 - ARIAANS; Gerardus Joseph Andreas ; et al.	2017-03-23
Anti-TNF alpha monoclonal secretory IgA antibodies and methods for treating inflammatory diseases Grant 9,580,501 - Ariaans , et al. February 28, 2	2017-02-28
Monoclonal antibodies to human proinflammatory cytokines and methods for treating inflammatory diseases Grant 9,573,996 - Ariaans , et al. February 21, 2	2017-02-21
Compounds And Methods For Treating Inflammatory Diseases App 20150166649 - Ariaans; Gerardus Joseph Andreas ; et al.	2015-06-18
Compounds And Methods For Treating Inflammatory Diseases App 20150010544 - Ariaans; Gerardus Joseph Andreas ; et al.	2015-01-08
Compounds And Methods For Treating Inflammatory Diseases App 20140356357 - Ariaans; Gerardus Joseph Andreas ; et al.	2014-12-04
EXPRESSION OF SECRETORY IgA ANTIBODIES IN DUCKWEED App 20140359902 - Ariaans; Gerardus Joseph Andreas ; et al.	2014-12-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.